The aim of this study is to compare the effectiveness of a combinatory product based on Echium amoenum with Citalopram in patients with depression. Patients are included in the study that have age more than 18 years old and Major depression criteria based on DSM-5, According to psychiatrist verdict. Patients are excluded with psychotic symptoms; Having a history of bipolar disorder; Having suicidal thoughts and any plans to do so; People with a history of recent emotional trauma; Patient dependence on chemical antidepressants; Pregnant and lactating women; Sensitivity to the citalopram; Sensitivity to herbal components of combinatory product; Addiction to alcohol and narcotics. Duration of this study is 8 week. Patients are allocated based on statistical software with Easy sampling method and they are enrolled in two groups of 25 people. To one group is given Citalopram pills and to other combinatory product based on Echium amoenum.
General information
Acronym
IRCT registration information
IRCT registration number:IRCT2015122725710N1
Registration date:2016-01-25, 1394/11/05
Registration timing:registered_while_recruiting
Last update:
Update count:0
Registration date
2016-01-25, 1394/11/05
Registrant information
Name
Mahdi Eslami
Name of organization / entity
Mashhad University of Medical Sciences
Country
Iran (Islamic Republic of)
Phone
+98 51 3605 7698
Email address
eslamim3@mums.ac.ir
Recruitment status
Recruitment complete
Funding source
Vice Chancellor for research of Mashhad University of Medical Sciences
Expected recruitment start date
2016-01-20, 1394/10/30
Expected recruitment end date
2016-06-20, 1395/03/31
Actual recruitment start date
empty
Actual recruitment end date
empty
Trial completion date
empty
Scientific title
Comparison the efficacy of a combinatory product based on Echium amoenum with Citalopram in Major depressive disorder.
Public title
Comparison the efficacy of a combinatory product based on Echium amoenum with Citalopram in Major depressive disorder.
Purpose
Treatment
Inclusion/Exclusion criteria
Inclusion criteria: Patients are enrolled with age more than 18 years and major depression based on DSM-5 criteria.
Exclusion criteria: Depression with psychotic symptoms; Having a history of bipolar disorder; Having suicidal thoughts and any plans to do so; People with a history of recent emotional trauma; Patient dependence on chemical antidepressants; Pregnant and lactating women; Sensitivity to the citalopram; Sensitivity to herbal components of combinatory product; Addiction to alcohol and narcotics
Age
From 18 years old
Gender
Both
Phase
3
Groups that have been masked
No information
Sample size
Target sample size:
50
Randomization (investigator's opinion)
N/A
Randomization description
Blinding (investigator's opinion)
Not blinded
Blinding description
Placebo
Not used
Assignment
Parallel
Other design features
Patients are allocated based on statistical software with Easy sampling method
Secondary Ids
empty
Ethics committees
1
Ethics committee
Name of ethics committee
Ethics committee of Mashhad University of Medical Sciences
Street address
Mashhad University of Medical Sciences, next to Hoveizeh cinema, Daneshgah street